Novel therapeutic and delivery strategies for primary auditory neuron regeneration

The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $824,505 Project Grant to the Sunnybrook Research Institute in Canada. The funding will support novel therapeutic and delivery strategies for primary auditory neuron regeneration research over a 3-year period from August 1, 2024 to July 31, 2027.

The Sunnybrook Research Institute, a leading Canadian biomedical research center, will leverage its expertise in neuroscience, biomarker development, and innovative medical research to investigate novel approaches for regenerating primary auditory neurons. This research aims to improve healthcare outcomes for military service members and the broader public by developing advanced treatment methods to address hearing-related conditions and injuries. The institute's world-class facilities and multidisciplinary collaborations with major U.S. research institutions will enable the translation of scientific discoveries into practical applications that benefit patients.